We are live on ! Find out more
RCMNY

Rubric Capital Management (New York) Portfolio holdings

AUM $9.44B
1-Year Est. Return 68.42%
This Fund
S&P 500
This Quarter Est. Return
+18.86%
1 Year Est. Return
+68.42%
3 Year Est. Return
+212.09%
5 Year Est. Return
+270.59%
10 Year Est. Return
–
AUM
$1.07B
AUM Growth
+$263M
Cap. Flow
+$161M
Cap. Flow %
15.05%
Top 10 Hldgs %
38.19%
Holding
78
New
29
Increased
11
Reduced
16
Closed
18

Top Buys

Rank Stock Value
1
SAIC icon
Saic
SAIC
+$45.2M
2
BERY
Berry Global Group, Inc.
BERY
+$35.7M
3
STML
Stemline Therapeutics, Inc.
STML
+$34M
4
TSN icon
Tyson Foods
TSN
+$26.7M
5
ENOV icon
Enovis
ENOV
+$25.8M

Top Sells

Rank Stock Value
1
INCY icon
Incyte
INCY
+$42.9M
2
ZAYO
Zayo Group Holdings, Inc.
ZAYO
+$39.1M
3
HRTX icon
Heron Therapeutics
HRTX
+$33.7M
4
PRTY
Party City Holdco Inc.
PRTY
+$25.1M
5
AGO icon
Assured Guaranty
AGO
+$22.1M

Sector Composition

Rank Sector Weight
1 Healthcare 38.78%
2 Technology 13.01%
3 Industrials 11.63%
4 Materials 8.42%
5 Financials 7.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SAIC icon
1
Saic
SAIC
$5.23B
$49.4M 4.61%
+642,053
New +$45.2M
VTRS icon
2
Viatris
VTRS
$19.6B
$48.2M 4.5%
1,700,000
+690,000
+68% +$20.1M
AMRN
3
Amarin Corp
AMRN
$305M
$46.7M 4.36%
112,500
+45,231
+67% +$16.3M
RDUS
4
DELISTED
Radius Health, Inc.
RDUS
$39.7M 3.71%
1,992,078
-107,922
-5% -$1.97M
STML
5
DELISTED
Stemline Therapeutics, Inc.
STML
$38.6M 3.61%
+3,005,000
New +$34M
ARNA
6
DELISTED
Arena Pharmaceuticals Inc
ARNA
$38.4M 3.59%
857,103
+213,706
+33% +$9.8M
BERY
7
DELISTED
Berry Global Group, Inc.
BERY
$37.8M 3.53%
764,368
+752,801
+6,508% +$35.7M
GPRE icon
8
Green Plains
GPRE
$1.09B
$37.1M 3.46%
2,221,529
-265,291
-11% -$3.98M
HRTX icon
9
Heron Therapeutics
HRTX
$95.8M
$36.7M 3.42%
1,500,000
-1,287,592
-46% -$33.7M
BHVN
10
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$36.4M 3.4%
707,952
-106,405
-13% -$4.6M
CHRS icon
11
Coherus Oncology
CHRS
$179M
$36M 3.36%
2,640,771
-409,229
-13% -$5.46M
COOP
12
DELISTED
Mr. Cooper
COOP
$34.8M 3.25%
3,626,116
-473,884
-12% -$6.36M
ENOV icon
13
Enovis
ENOV
$1.55B
$30.1M 2.81%
+588,429
New +$25.8M
TSN icon
14
Tyson Foods
TSN
$20.5B
$29.9M 2.79%
+430,700
New +$26.7M
WSC icon
15
WillScot Mobile Mini Holdings
WSC
$4.74B
$29.7M 2.77%
2,676,000
+504,262
+23% +$5.24M
J icon
16
Jacobs Solutions
J
$16.8B
$25.2M 2.35%
+405,126
New +$22.8M
BRSL
17
Brightstar Lottery PLC
BRSL
$2B
$24.3M 2.27%
1,869,904
-1,130,096
-38% -$17.4M
TH icon
18
Target Hospitality
TH
$1.61B
$23.8M 2.22%
+2,500,000
New +$25.2M
BGC icon
19
BGC Group
BGC
$4.91B
$23.6M 2.2%
4,435,899
-340,953
-7% -$2.03M
SYNH
20
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
$23.1M 2.16%
+446,705
New +$21.7M
MBI icon
21
MBIA
MBI
$270M
$23M 2.14%
2,411,400
– –
TXMD icon
22
TherapeuticsMD
TXMD
$24.1M
$22.8M 2.13%
93,819
+62,914
+204% +$16.6M
CNDT icon
23
Conduent
CNDT
$271M
$21.9M 2.05%
1,584,000
+1,010,705
+176% +$13.5M
MX icon
24
Magnachip Semiconductor
MX
$147M
$21.1M 1.97%
2,855,503
-144,497
-5% -$1.03M
AVYA
25
DELISTED
Avaya Holdings Corp. Common Stock
AVYA
$19.5M 1.82%
1,160,004
-1,094,147
-49% -$17.1M
1
2 3 4

Similar funds

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SIM
SRS Investment Management New York $9.47B AUM 60.12% 1-Year Est. Return
NPT
National Philanthropic Trust Jenkintown, Pennsylvania $9.38B AUM 33.37% 1-Year Est. Return
AC
Allstate Corporation Northbrook, Illinois $9.35B AUM 16.13% 1-Year Est. Return
PVI
Partners Value Investments Hamilton, Bermuda $9.34B AUM 12.2% 1-Year Est. Return
WPL
WINDACRE PARTNERSHIP LLC Houston, Texas $9.34B AUM 17.41% 1-Year Est. Return
BAMF
BI Asset Management Fondsmaeglerselskab Kobenhavn, Denmark $9.55B AUM 31.94% 1-Year Est. Return
IAA
Independent Advisor Alliance Charlotte, North Carolina $9.32B AUM 33.19% 1-Year Est. Return

Rubric Capital Management (New York)'s Q1 2019 Portfolio in Review

As of Q1 2019, Rubric Capital Management (New York) held 78 positions worth $1.07B, up 33% from $808M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Rubric Capital Management (New York) deployed $161M of net new capital in Q1 2019, opening 29 new positions and adding to 11 existing holdings. Its largest new stake was Saic: 642,053 shares worth $49.4M.

By sector, the portfolio is most concentrated in Healthcare at 39% of assets, up from 36% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Heron Therapeutics, an estimated $33.7M trimmed.

  • Rubric Capital Management (New York)'s largest Q1 2019 buy was Saic: 642,053 shares worth $49.4M.
  • Rubric Capital Management (New York) added most to Berry Global Group, Inc. in Q1 2019, an estimated $35.7M increase.
  • Rubric Capital Management (New York)'s biggest Q1 2019 reduction was Heron Therapeutics, cutting an estimated $33.7M.
  • Rubric Capital Management (New York) fully exited Incyte in Q1 2019, selling an estimated $42.9M.
  • Rubric Capital Management (New York)'s ten largest holdings make up 38% of its $1.07B portfolio in Q1 2019.
  • Rubric Capital Management (New York) opened 29 new positions and closed 18 in Q1 2019.
  • Rubric Capital Management (New York)'s portfolio value rose 33% quarter-over-quarter to $1.07B.

Based on Rubric Capital Management (New York)'s 13F filing for Q1 2019, filed 10 May 2019.